Topiramate (drug)

DRUG4 trials

Sponsors

Baylor College of Medicine, University Health Network, Toronto, Erasmus Medical Center

Conditions

HIV (Human Immunodeficiency Virus)HIV -1 InfectionParkinson's DiseaseTourette Syndrome

Phase 1

Combining Latency Reversing Agents to Address the HIV Reservoir

Not yet recruitingNCT07384624

Erasmus Medical CenterHIV -1 Infection, HIV (Human Immunodeficiency Virus)

Start: 2026-04-01End: 2028-07-01Target: 30Updated: 2026-02-03

Phase 2

Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

TerminatedNCT00296959

University Health Network, TorontoParkinson's Disease

Start: 2004-09-30End: 2007-03-31Target: 20Updated: 2007-09-20

Phase 3

A Randomized, Placebo-controlled, Tourette Syndrome Study.

CompletedNCT00206323

Baylor College of MedicineTourette Syndrome

Start: 2004-09-30End: 2008-12-31Updated: 2020-02-12

An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

CompletedNCT00206336

Baylor College of MedicineTourette Syndrome

Start: 2004-10-31End: 2008-12-31Updated: 2017-11-06